CSPC PHARMA (01093.HK) Stock Community - Hot Topic Discussions

Quote List Quote List

Event Tracking

Dec19

Jade Pharmaceutical's SYH2085 Approved for Clinical Trials in China

13:18

Dec18

Sukoddju Injection Phase III Clinical Trial Achieves Positive Results for Severe Plaque Psoriasis Treatment

10:20

Dec17

Morgan Stanley Downgrades JP Group’s Target Price and Adjusts Profit Projections

03:11

Dec15

Shire Pharmaceutical Group's Liposomal Irinotecan Injection Approved for New Indication

00:50

Dec12

Stone Pharmaceutical's Liposomal Irinotecan Injection Approved for First-Line Pancreatic Cancer Treatment

10:26

Dec10

Stone Pharmaceutical Group Secures FDA Approval for Weight Management Drug Trial

11:48

Schedules & Filings

Schedules

Filings

Nov20

Earning Release(CST)

FY2025 Q3 Earning Release (HKD) Revenue 7.234 B, Net Income 1.053 B, EPS 0.0921

Nov18

Distribution Plan(CST)

Cash dividend 0.14 HKD

Oct20

Distribution Plan(CST)

Cash dividend 0.14 HKD

Stock List

Top Gainers

Top Decliners

Main Board

Symbol

Price

%Chg

Change